ArticleMedecine tropicale et sante internationale2026
[Genu recurvatum: a serious complication of intra-quadriceps injections in the African context].
Article in Medecine tropicale et sante internationale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Genu recurvatum is a serious complication of intra-quadriceps injections. Materials and methods: This study reports on 25 cases of genu recurvatum collected during 104 pediatric orthopedic surgery missions in the Central African Republic. Of these cases, 12 could be reviewed with sufficient follow-up and/or radiographic evaluation. Results: Genu recurvatum impairs walking and makes running impossible. It becomes extremely severe when it is bilateral or exceeds 90°. Treatment options are limited due to osteoarticular changes that occur during growth. These changes include trochlear hypoplasia, flattening of the anterior aspect of the femoral condyles, and anterior subluxation of the tibia. Despite the fact that the genu recurvatum was corrected immediately postoperatively, the knee was stiff in extension in all but one of the reviewed cases. Conclusion: Fortunately, intra-quadriceps injections are currently prohibited, so this complication should become rare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.